Lataa...
SAT-498 Use of Cinacalcet for PTHrP-Mediated Hypercalcemia of Malignancy in Penile Squamous Cell Carcinoma
Background: PTHrP-mediated hypercalcemia accounts for 80% of hypercalcemia of malignancy (HCM), and is traditionally treated with bisphosphonates or hemodialysis. We report a patient with penile squamous cell carcinoma (SCC) and bisphosphonate resistant PTHrP-mediated HCM that responded to calcimime...
Tallennettuna:
| Julkaisussa: | J Endocr Soc |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Endocrine Society
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552553/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-498 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|